Abstract
Objective: We retrospectively investigate the prevalence of gynecomastia as false-positive 2-[18F]fluoro-2-deoxy-d-glucose (18F-FDG) positron emission tomography (PET)/computed tomography (CT) imaging in patients with hepatocellular carcinoma (HCC). Methods: Among the 127 male HCC patients who underwent 18F-FDG PET/CT scan, the 18FDG uptakes at the bilateral breasts in 9 patients with gynecomastia were recorded as standard uptake value (SUVmax) and the visual interpretation in both early and delayed images. Results: The mean early SUVmax was 1.58/1.57 (right/left breast) in nine gynecomastia patients. The three patients with early visual score of 3 had higher early SUVmaxs. Conclusion: Gynecomastia is a possible cause of false-positive uptake on 18F-FDG PET/CT images.
| Original language | English |
|---|---|
| Pages (from-to) | 942-946 |
| Number of pages | 5 |
| Journal | Clinical Imaging |
| Volume | 37 |
| Issue number | 5 |
| DOIs | |
| State | Published - 09 2013 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- FDG PET/CT
- Gynecomastia
- Hepatocellular carcinoma
- SUVmax
Fingerprint
Dive into the research topics of '18F-FDG PET/CT in detection of gynecomastia in patients with hepatocellular carcinoma'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver